Catharina Ziekenhuis Eindhoven
catharinaziekenhuis.nlTotal trials
81
Active
10
Phase 3
2
Total enrollment
18,376
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combination drug | — | — | — | — | — | 1 | |
| FOLFOXIRI Protocol | — | — | — | — | — | 1 | |
| Imiquimod | — | — | — | — | — | 1 |
Next readouts
- 2024-03-01
- 2024-12
- 2025-06-01
Top conditions
- Coronary Artery Disease6
- Atrial Fibrillation4
- Heart Failure4
- Acute Myocardial Infarction3
- Intubation Complication3
- Osteoporosis3
- Cardiac Output, High3
- Aortic Valve Disease2
Frequently asked questions about Catharina Ziekenhuis Eindhoven
- How many clinical trials does Catharina Ziekenhuis Eindhoven have on ClinicalTrials.gov?
- Catharina Ziekenhuis Eindhoven is listed as the lead sponsor on 81 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Catharina Ziekenhuis Eindhoven's trials are in Phase 3?
- 2 of Catharina Ziekenhuis Eindhoven's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Catharina Ziekenhuis Eindhoven focus on?
- Catharina Ziekenhuis Eindhoven's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Atrial Fibrillation, Heart Failure, Acute Myocardial Infarction, Intubation Complication.
- When are Catharina Ziekenhuis Eindhoven's next clinical trial readouts?
- Catharina Ziekenhuis Eindhoven has 3 upcoming primary-completion readouts tracked here; the soonest is “Induction Chemotherapy for Locally Recurrent Rectal Cancer”, expected around 2024-03-01.